Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2023/7/6 申報
- 申報編號
- 0001968202-23-000016
- 申報時間
- 2023/7/6
- 交易日
- 2023/7/3
- 申報延遲
- 3 天
- 10b5-1 計畫
- 有勾選
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $7.17 萬。交易後 3 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/7/3 | Common Stock | S賣出處分 | −1 | $710.09 | −$710.09 | 18,846 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −1 | $711.95 | −$711.95 | 18,845 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −6 | $713.82 | −$4,282.92 | 18,839 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −10 | $714.65F2 | −$7,146.5 | 18,829 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −7 | $715.23F3 | −$5,006.61 | 18,822 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −29 | $716.74F4 | −$20,785.46 | 18,793 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −22 | $717.57F5 | −$15,786.54 | 18,771 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −12 | $718.71F6 | −$8,624.52 | 18,759 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −11 | $719.36F7 | −$7,912.96 | 18,748 | 直接 | |
| 2023/7/3 | Common Stock | S賣出處分 | −1 | $720.15 | −$720.15 | 18,747 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 10 shares of Company stock on July 3, 2023 at prices ranging from $714.17 to $714.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 7 shares of Company stock on July 3, 2023 at prices ranging from $715.02 to $715.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 29 shares of Company stock on July 3, 2023 at prices ranging from $716.09 to $716.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 22 shares of Company stock on July 3, 2023 at prices ranging from $717.22 to $717.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 12 shares of Company stock on July 3, 2023 at prices ranging from $718.47 to $718.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 11 shares of Company stock on July 3, 2023 at prices ranging from $719.05 to $719.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。